Stocks Overview

LAST PRICE
27.0000
TODAY'S CHANGE (%)
Trending Down-0.0200 (-0.0740%)

Bid / Lots
26.5000/ 2
Ask / Lots
27.3000/ 1
Open / Previous Close
27.1600 / 27.0200
Day Range
Low 26.9400
High 27.2600
52 Week Range
Low 25.9200
High 34.6500
Volume
2,163,345
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Tuesday's close: 27.02
Time	Volume	RPRX
09:32 ET	65935	27.2
09:34 ET	4103	27.19
09:36 ET	3039	27.26
09:38 ET	2491	27.125
09:39 ET	6359	27.04
09:41 ET	6704	27.02
09:43 ET	12551	27.05
09:45 ET	4099	27.01
09:48 ET	2414	27.01
09:50 ET	4292	27
09:52 ET	9650	26.95
09:54 ET	7222	26.99
09:56 ET	37682	26.985
09:57 ET	17425	27.01
09:59 ET	4432	27.015
10:01 ET	27111	27.015
10:03 ET	3290	27.05
10:06 ET	5151	27.045
10:08 ET	6265	27
10:10 ET	5727	27.03
10:12 ET	6980	27.04
10:14 ET	3400	27.06
10:15 ET	4627	27.055
10:17 ET	4558	27.025
10:19 ET	3496	27.045
10:21 ET	1500	27.055
10:24 ET	7276	27.06
10:26 ET	5400	27.06
10:28 ET	2959	27.045
10:30 ET	3035	27.07
10:32 ET	3503	27.035
10:33 ET	6476	27.035
10:35 ET	2229	27.045
10:37 ET	3322	27.055
10:39 ET	2336	27.065
10:42 ET	4796	27.06
10:44 ET	4431	27.065
10:46 ET	2600	27.06
10:48 ET	1814	27.045
10:50 ET	2782	27.045
10:51 ET	4027	27.035
10:53 ET	1301	27.045
10:55 ET	2736	27.035
10:57 ET	4457	27.025
11:00 ET	4314	27.05
11:02 ET	2444	27.075
11:04 ET	4167	27.07
11:06 ET	500	27.065
11:08 ET	4312	27.055
11:09 ET	1515	27.055
11:11 ET	4422	27.07
11:13 ET	2374	27.06
11:15 ET	1750	27.075
11:18 ET	3400	27.045
11:20 ET	4719	27.04
11:22 ET	4196	27.01
11:24 ET	3861	27.035
11:26 ET	6421	27.045
11:27 ET	4800	27.05
11:29 ET	3970	27.075
11:31 ET	1586	27.075
11:33 ET	6226	27.075
11:36 ET	8299	27.095
11:38 ET	1900	27.095
11:40 ET	9736	27.06
11:42 ET	5777	27.0492
11:44 ET	4714	27.055
11:45 ET	6837	27.065
11:47 ET	4604	27.035
11:49 ET	4501	27.05
11:51 ET	2320	27.055
11:54 ET	4657	27.045
11:56 ET	2100	27.02
11:58 ET	800	27.025
12:00 ET	2130	27.015
12:02 ET	3565	27.015
12:03 ET	7037	27.01
12:05 ET	1700	27.005
12:07 ET	2768	26.985
12:09 ET	7841	27.005
12:12 ET	90962	27.005
12:14 ET	2783	27.015
12:16 ET	12697	27.015
12:18 ET	2475	27.0137
12:20 ET	3674	27.015
12:21 ET	1400	27.025
12:23 ET	2600	27.035
12:25 ET	2492	27.035
12:27 ET	685	27.035
12:30 ET	1600	27.045
12:32 ET	15239	27.09
12:34 ET	3771	27.105
12:36 ET	4293	27.095
12:38 ET	4651	27.14
12:39 ET	4900	27.15
12:41 ET	1900	27.155
12:43 ET	9696	27.1275
12:45 ET	14405	27.135
12:48 ET	6396	27.135
12:50 ET	500	27.135
12:52 ET	1900	27.145
12:54 ET	7233	27.095
12:56 ET	9592	27.095
12:57 ET	1300	27.095
12:59 ET	2254	27.085
01:01 ET	5244	27.065
01:03 ET	5141	27.085
01:06 ET	3442	27.06
01:08 ET	3030	27.07
01:10 ET	200	27.075
01:12 ET	2037	27.075
01:14 ET	2100	27.08
01:15 ET	3166	27.085
01:17 ET	3155	27.055
01:19 ET	1940	27.07
01:21 ET	833	27.065
01:24 ET	2335	27.075
01:26 ET	5089	27.065
01:28 ET	8497	27.055
01:30 ET	3030	27.085
01:32 ET	2199	27.075
01:33 ET	2519	27.075
01:35 ET	2053	27.05
01:37 ET	400	27.05
01:39 ET	1000	27.05
01:42 ET	27397	27.035
01:44 ET	2648	27.045
01:46 ET	1695	27.04
01:48 ET	5200	27.055
01:50 ET	2833	27.03
01:51 ET	6437	27.045
01:53 ET	1795	27.065
01:55 ET	100	27.065
01:57 ET	4426	27.085
02:00 ET	5868	27.075
02:02 ET	4822	27.08
02:04 ET	1350	27.075
02:06 ET	4553	27.075
02:08 ET	8454	27.11
02:09 ET	7617	27.125
02:11 ET	1740	27.125
02:13 ET	3048	27.11
02:15 ET	1879	27.095
02:18 ET	1154	27.095
02:20 ET	10723	27.11
02:22 ET	100	27.115
02:24 ET	1211	27.12
02:26 ET	1213	27.115
02:27 ET	10787	27.135
02:29 ET	2998	27.135
02:31 ET	11276	27.125
02:33 ET	5843	27.135
02:36 ET	6088	27.145
02:38 ET	5321	27.1599
02:40 ET	4204	27.135
02:42 ET	4601	27.135
02:44 ET	2932	27.135
02:45 ET	9666	27.11
02:47 ET	9409	27.115
02:49 ET	1380	27.115
02:51 ET	3865	27.125
02:54 ET	4981	27.135
02:56 ET	9799	27.135
02:58 ET	3084	27.115
03:00 ET	4740	27.145
03:02 ET	3606	27.145
03:03 ET	8550	27.155
03:05 ET	6940	27.13
03:07 ET	4615	27.125
03:09 ET	8766	27.115
03:12 ET	2728	27.115
03:14 ET	5245	27.115
03:16 ET	9021	27.095
03:18 ET	4252	27.105
03:20 ET	8505	27.105
03:21 ET	9558	27.105
03:23 ET	4414	27.105
03:25 ET	12523	27.07
03:27 ET	10431	27.085
03:30 ET	4057	27.085
03:32 ET	6656	27.04
03:34 ET	15428	27.045
03:36 ET	3553	27.03
03:38 ET	18627	27.02
03:39 ET	1272	27.025
03:41 ET	17047	27.015
03:43 ET	5157	27
03:45 ET	14621	27.005
03:48 ET	11942	26.99
03:50 ET	5378	26.96
03:52 ET	23006	26.955
03:54 ET	18480	26.97
03:56 ET	51205	26.995
03:57 ET	60323	27.005
03:59 ET	380399	27

Data delayed at least 15 minutes.

Yesterday
- Royalty Pharma to Present at the Goldman Sachs 45th Annual Global Healthcare Conference, from 4:15PM ET on Tuesday Jun 04, 2024 by Dow Jones
  4:15PM ET on Tuesday Jun 04, 2024 by Dow Jones
Jun 3, 2024
- Press Release: Royalty Pharma Announces Pricing of $1.5 Billion of Senior Unsecured Notes, from 5:15PM ET on Monday Jun 03, 2024 by Dow Jones
  5:15PM ET on Monday Jun 03, 2024 by Dow Jones
- Royalty Pharma Announces Pricing of $1.5 Billion of Senior Unsecured Notes, from 5:15PM ET on Monday Jun 03, 2024 by Dow Jones
  5:15PM ET on Monday Jun 03, 2024 by Dow Jones
- DJ Royalty Pharma Cut to Neutral From Buy by UBS, from 12:00PM ET on Monday Jun 03, 2024 by Dow Jones
  12:00PM ET on Monday Jun 03, 2024 by Dow Jones
May 29, 2024
- DJ S&P 500 Futures Fall In Premarket Trading; Bank OZK, American Airlines Group Lag, from 7:30AM ET on Wednesday May 29, 2024 by Dow Jones
  7:30AM ET on Wednesday May 29, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesRPRX Royalty Pharma PLC	16.4B	15.1x	+1.83%
United StatesAMRX Amneal Pharmaceuticals Inc	2.1B	-12.1x	---
United StatesCTLT Catalent Inc	9.7B	-8.6x	---
United StatesJAZZ Jazz Pharmaceuticals PLC	6.6B	22.0x	-3.53%
United StatesMCKPF Mallinckrodt PLC	1.6M	0.0x	---
United StatesPBH Prestige Consumer Healthcare Inc	3.2B	15.5x	---
As of 2024-06-05

Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio consists of royalties on over 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 14 development-stage product candidates. Its development-stage product candidates include Aficamten, Ampreloxetine, BCX10013, MK-8189, Ecopipam, Olpasiran, Pelabresib, KarXT, Pelacarsen, Seltorexant, Trontinemab, TEV-'749, Tulmimetostat and Vanzacaftor. Its subsidiaries include Royalty Pharma Holdings Ltd., Royalty Pharma Investments and others.

Contact Information

Headquarters: 110 East 59th StreetNEW YORK, NY, United States 10022
Phone: 212-883-0200
Fax: ---

Executives

Chairman of the Board, Chief Executive Officer: Pablo Legorreta
Vice Chairman, Executive Vice President: Christopher Hite
Chief Financial Officer, Executive Vice President: Terrance Coyne
Executive Vice President - Investments and Chief Legal Officer: George Lloyd
Executive Vice President - Research and Investments: Marshall Urist

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$16.4B
Revenue (TTM)	$2.2B
Shares Outstanding	597.4M
Dividend Yield	3.11%
Annual Dividend Rate	0.8400 USD
Ex-Dividend Date	05-16-24
Pay Date	06-14-24
Beta	0.47
EPS	$1.78
Book Value	$14.61
P/E Ratio	15.1x
Price/Sales (TTM)	7.3
Price/Cash Flow (TTM)	13.7x
Operating Margin	41.96%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Royalty Pharma PLC
NASDAQ:RPRXUnited States

Search Criteria

Charts

Recent News

Yesterday

Royalty Pharma to Present at the Goldman Sachs 45th Annual Global Healthcare Conference, from 4:15PM ET on Tuesday Jun 04, 2024 by Dow Jones

Jun 3, 2024

Press Release: Royalty Pharma Announces Pricing of $1.5 Billion of Senior Unsecured Notes, from 5:15PM ET on Monday Jun 03, 2024 by Dow Jones

Royalty Pharma Announces Pricing of $1.5 Billion of Senior Unsecured Notes, from 5:15PM ET on Monday Jun 03, 2024 by Dow Jones

DJ Royalty Pharma Cut to Neutral From Buy by UBS, from 12:00PM ET on Monday Jun 03, 2024 by Dow Jones

May 29, 2024

DJ S&P 500 Futures Fall In Premarket Trading; Bank OZK, American Airlines Group Lag, from 7:30AM ET on Wednesday May 29, 2024 by Dow Jones

Pharmaceuticals - Diversified Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar